These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38349538)

  • 1. High-volume facilities are significantly more likely to use guideline-adherent systemic immunotherapy for metastatic Merkel cell carcinoma: implications for cancer care regionalization.
    Cheraghlou S; Pahalyants V; Jairath NK; Doudican NA; Carucci JA
    Arch Dermatol Res; 2024 Feb; 316(3):86. PubMed ID: 38349538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line Immunotherapy for Metastatic Merkel Cell Carcinoma: Analysis of Real-world Survival Data and Practice Patterns.
    Kakish H; Sun J; Ammori JB; Hoehn RS; Rothermel LD
    Am J Clin Oncol; 2024 Aug; 47(8):357-362. PubMed ID: 38587336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
    Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
    Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world clinical outcomes with first-line avelumab in locally advanced/metastatic Merkel cell carcinoma in the USA: SPEAR-Merkel.
    Cowey CL; Liu FX; Kim R; Boyd M; Fulcher N; Krulewicz S; Kasturi V; Bhanegaonkar A
    Future Oncol; 2021 Jun; 17(18):2339-2350. PubMed ID: 33709776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of facility characteristics on Merkel cell carcinoma outcomes: A retrospective cohort study.
    Cheraghlou S; Agogo GO; Girardi M
    J Am Acad Dermatol; 2023 Jul; 89(1):70-80. PubMed ID: 31473294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study.
    Bhatia S; Nghiem P; Veeranki SP; Vanegas A; Lachance K; Tachiki L; Chiu K; Boller E; Bharmal M
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35981787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR-Merkel.
    Bhanegaonkar A; Liu FX; Boyd M; Fulcher N; Kim R; Krulewicz S; Smith J; Cowey CL
    Oncologist; 2021 Sep; 26(9):e1633-e1643. PubMed ID: 34101298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
    Paulson KG; Bhatia S
    J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avelumab: a new standard for treating metastatic Merkel cell carcinoma.
    Baker M; Cordes L; Brownell I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for Merkel Cell Carcinoma.
    Nagase K; Narisawa Y
    Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative metastatic lymph node burden and survival in Merkel cell carcinoma.
    Nguyen AT; Luu M; Lu DJ; Hamid O; Mallen-St Clair J; Faries MB; Gharavi NM; Ho AS; Zumsteg ZS
    J Am Acad Dermatol; 2021 Feb; 84(2):312-320. PubMed ID: 31954753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and Neck.
    Jacobs D; Olino K; Park HS; Clune J; Cheraghlou S; Girardi M; Burtness B; Kluger H; Judson BL
    Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1214-1221. PubMed ID: 33079010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merkel Cell Carcinoma of Unknown Primary Origin.
    Francetić H; Simetić L; Tomasović Lončarić Č; Štulhofer Buzina D; Čeović R
    Acta Dermatovenerol Croat; 2023 Dec; 31(3):153-155. PubMed ID: 38439727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial.
    D'Angelo SP; Russell J; Lebbé C; Chmielowski B; Gambichler T; Grob JJ; Kiecker F; Rabinowits G; Terheyden P; Zwiener I; Bajars M; Hennessy M; Kaufman HL
    JAMA Oncol; 2018 Sep; 4(9):e180077. PubMed ID: 29566106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database.
    Mortier L; Blom A; van Hille B; Samimi M; Luciani L; Cahuzac C; Robert C; Quereux G; Maubec E; Miotti H; Maillard C; Aubin F; Lenormand C; Solbes MN; Joly P; Kachaner I; Lebbé C; Dutriaux C; Saiag P
    Eur J Cancer; 2024 Sep; 209():114261. PubMed ID: 39128185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.
    Bhatia S; Storer BE; Iyer JG; Moshiri A; Parvathaneni U; Byrd D; Sober AJ; Sondak VK; Gershenwald JE; Nghiem P
    J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27245173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avelumab for the treatment of locally advanced or metastatic Merkel cell carcinoma-A multicenter real-world experience in Israel.
    Averbuch I; Stoff R; Miodovnik M; Fennig S; Bar-Sela G; Yakobson A; Daliot J; Asher N; Fenig E
    Cancer Med; 2023 Jun; 12(11):12065-12070. PubMed ID: 37012213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Benefit of Guideline-Concordant Postoperative Radiation for Local Merkel Cell Carcinoma.
    Wong WG; Stahl K; Olecki EJ; Holguin RP; Pameijer C; Shen C
    J Surg Res; 2021 Oct; 266():168-179. PubMed ID: 34015514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Lymph Node Ratio Association With Long-term Patient Survival After Surgery for Node-Positive Merkel Cell Carcinoma.
    Cheraghlou S; Agogo GO; Girardi M
    JAMA Dermatol; 2019 Jul; 155(7):803-811. PubMed ID: 30825411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.
    Bhatia S; Afanasiev O; Nghiem P
    Curr Oncol Rep; 2011 Dec; 13(6):488-97. PubMed ID: 21953511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.